Agreed. A market cap of $20m doesn't go anywhere near accurately...

Agreed.

A market cap of $20m doesn't go anywhere near accurately valuing where EMS are in terms of artimist commercialisation.
But that's ok, as it has provided a great buying opportunity once again.

IMO the best time to buy is when no one else is.

Fwiw my understanding is that Steve does not have a speaking spot. It doesn't mean the conference won't be extremely useful though, as IMO many politicians and delegates will be hearing about artimist for the first time.
That can only be a good thing